ClearPoint Neuro (CLPT) Equity Average (2012 - 2026)
ClearPoint Neuro recorded quarterly Equity Average of $23.4 million in Q1 2026, up 6.76% quarter-over-quarter from $21.9 million in Q4 2025, and up 3.27% year-over-year from $22.7 million in Q1 2025.
ClearPoint Neuro's Equity Average history runs 15 years deep, the most recent figure standing at $23.4 million for Q1 2026.
- In Q1 2026, Equity Average rose 3.27% year-over-year to $23.4 million; the TTM figure through Mar 2026 stood at $23.4 million (up 3.27% YoY), while the FY2025 annual figure was $26.7 million, up 14.71% from the prior year.
- Equity Average came in at $23.4 million for Q1 2026 at ClearPoint Neuro, up from $21.9 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $47.3 million in Q1 2022 to a low of $17.8 million in Q3 2025.
- A 5-year average of $29.9 million and a median of $27.9 million in 2024 frame the typical range for Equity Average.
- Across the five-year window, Equity Average surged 103.88% in 2022 and tumbled 41.74% in 2025, its largest moves.
- ClearPoint Neuro's Equity Average stood at $38.4 million in 2022, then tumbled by 41.03% to $22.6 million in 2023, then advanced by 20.15% to $27.2 million in 2024, then declined by 19.3% to $21.9 million in 2025, then advanced by 6.76% to $23.4 million in 2026.
- According to Business Quant data, Equity Average over the past three periods registered $23.4 million, $21.9 million, and $17.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 23.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 23.43 Mn |
| Dec 31, 2025 | 21.95 Mn |
| Sep 30, 2025 | 17.81 Mn |
| Jun 30, 2025 | 19.87 Mn |
| Mar 31, 2025 | 22.69 Mn |
| Dec 31, 2024 | 27.20 Mn |
| Sep 30, 2024 | 30.57 Mn |
| Jun 30, 2024 | 33.36 Mn |
| Mar 31, 2024 | 27.88 Mn |
| Dec 31, 2023 | 22.63 Mn |
| Sep 30, 2023 | 25.75 Mn |
| Jun 30, 2023 | 30.00 Mn |
| Mar 31, 2023 | 34.73 Mn |
| Dec 31, 2022 | 38.38 Mn |
| Sep 30, 2022 | 41.35 Mn |
| Jun 30, 2022 | 44.28 Mn |
| Mar 31, 2022 | 47.26 Mn |
| Dec 31, 2021 | 46.45 Mn |
| Sep 30, 2021 | 46.04 Mn |
| Jun 30, 2021 | 45.97 Mn |
| Mar 31, 2021 | 23.18 Mn |
| Dec 31, 2020 | 1.26 Mn |
| Sep 30, 2020 | 744,000.00 |
| Jun 30, 2020 | 2.05 Mn |
| Mar 31, 2020 | 3.67 Mn |
| Dec 31, 2019 | 5.30 Mn |
| Sep 30, 2019 | 6.46 Mn |
| Jun 30, 2019 | 3.67 Mn |
| Mar 31, 2019 | 976,309.50 |
| Dec 31, 2018 | 2.00 Mn |
| Sep 30, 2018 | 3.03 Mn |
| Jun 30, 2018 | 4.15 Mn |
| Mar 31, 2018 | 5.29 Mn |
| Dec 31, 2017 | 2.54 Mn |
| Dec 31, 2016 | -90,742.00 |
| Sep 30, 2016 | -1.70 Mn |
| Jun 30, 2016 | -3.79 Mn |
| Mar 31, 2016 | -2.80 Mn |
| Dec 31, 2015 | -3.90 Mn |
| Sep 30, 2015 | -5.85 Mn |
| Jun 30, 2015 | -4.76 Mn |
| Mar 31, 2015 | -1.87 Mn |
| Dec 31, 2014 | -4.01 Mn |
| Sep 30, 2014 | -6.22 Mn |
| Jun 30, 2014 | -3.82 Mn |
| Mar 31, 2014 | -4.99 Mn |
| Dec 31, 2013 | -6.22 Mn |
| Sep 30, 2013 | -4.22 Mn |
| Jun 30, 2013 | -2.34 Mn |
| Mar 31, 2013 | -4.87 Mn |
| Dec 31, 2012 | -8.64 Mn |
| Sep 30, 2012 | -10.08 Mn |
| Jun 30, 2012 | -11.72 Mn |
| Mar 31, 2012 | -17.27 Mn |